Literature DB >> 21816901

HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription.

Alyson A Fiorillo1, Terry R Medler, Yvonne B Feeney, Yi Liu, Kalie L Tommerdahl, Charles V Clevenger.   

Abstract

The direct actions of transmembrane receptors within the nucleus remain enigmatic. In this report, we demonstrate that the prolactin receptor (PRLr) localizes to the nucleus where it functions as a coactivator through its interactions with the latent transcription factor signal transducer and activator of transcription 5a (Stat5a) and the high-mobility group N2 protein (HMGN2). We identify a novel transactivation domain within the PRLr that is activated by ligand-induced phosphorylation, an event coupled to HMGN2 binding. The association of the PRLr with HMGN2 enables Stat5a-responsive promoter binding, thus facilitating transcriptional activation and promoting anchorage-independent growth. We propose that HMGN2 serves as a critical regulatory factor in Stat5a-driven gene expression by facilitating the assembly of PRLr/Stat5a onto chromatin and that these events may serve to promote biological events that contribute to a tumorigenic phenotype. Our data imply that phosphorylation may be the molecular switch that activates a cell surface receptor transactivation domain, enabling it to tether chromatin-modifying factors, such as HMGN2, to target promoter regions in a sequence-specific manner.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816901      PMCID: PMC5417234          DOI: 10.1210/me.2011-0106

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  63 in total

1.  Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes.

Authors:  J E Herrera; K Sakaguchi; M Bergel; L Trieschmann; Y Nakatani; M Bustin
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.

Authors:  S E Hankinson; W C Willett; D S Michaud; J E Manson; G A Colditz; C Longcope; B Rosner; F E Speizer
Journal:  J Natl Cancer Inst       Date:  1999-04-07       Impact factor: 13.506

3.  Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.

Authors:  Hui-Wen Lo; Weiya Xia; Yongkun Wei; Mohamed Ali-Seyed; Shiu-Feng Huang; Mien-Chie Hung
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

Review 4.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

5.  Nuclear localization of a complex of fibroblast growth factor(FGF)-1 and an NH2-terminal fragment of FGF receptor isoforms R4 and R1alpha in human liver cells.

Authors:  S Feng; J Xu; F Wang; M Kan; W L McKeehan
Journal:  Biochim Biophys Acta       Date:  1996-01-10

6.  Nuclear localization of EGF receptor and its potential new role as a transcription factor.

Authors:  S Y Lin; K Makino; W Xia; A Matin; Y Wen; K Y Kwong; L Bourguignon; M C Hung
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

7.  Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells.

Authors:  D T Lincoln; F Sinowatz; L Temmim-Baker; H I Baker; S Kölle; M J Waters
Journal:  Histochem Cell Biol       Date:  1998-02       Impact factor: 4.304

8.  Chromosomal proteins HMG-14 and HMG-17. Distinct multigene families coding for similar types of transcripts.

Authors:  D Landsman; M Bustin
Journal:  J Biol Chem       Date:  1986-12-05       Impact factor: 5.157

9.  NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the alpha-helical region of the STAT5 transactivation domain.

Authors:  Claudia M Litterst; Stefanie Kliem; Dominique Marilley; Edith Pfitzner
Journal:  J Biol Chem       Date:  2003-09-03       Impact factor: 5.157

10.  Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer.

Authors:  Matthew J LeBaron; Jianwu Xie; Hallgeir Rui
Journal:  Mol Cancer       Date:  2005-02-01       Impact factor: 27.401

View more
  10 in total

1.  HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.

Authors:  Terry R Medler; Justin M Craig; Alyson A Fiorillo; Yvonne B Feeney; J Chuck Harrell; Charles V Clevenger
Journal:  Mol Cancer Res       Date:  2016-06-29       Impact factor: 5.852

Review 2.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

3.  The nucleosome binding protein HMGN1 interacts with PCNA and facilitates its binding to chromatin.

Authors:  Yuri V Postnikov; Toshihiro Kurahashi; Ming Zhou; Michael Bustin
Journal:  Mol Cell Biol       Date:  2012-03-05       Impact factor: 4.272

4.  Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.

Authors:  Suzanne M Schauwecker; J Julie Kim; Jonathan D Licht; Charles V Clevenger
Journal:  J Biol Chem       Date:  2016-12-29       Impact factor: 5.157

5.  Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.

Authors:  Qian Li; Jiao Chen; Xiaoying Li; Bomiao Cui; Yaping Fan; Ning Geng; Qianming Chen; Ping Zhang; Yun Feng
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

6.  The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Suzanne M Wetz; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Am J Pathol       Date:  2012-11-14       Impact factor: 4.307

7.  Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family.

Authors:  Ying-Nai Wang; Mien-Chie Hung
Journal:  Cell Biosci       Date:  2012-04-20       Impact factor: 7.133

8.  The modulation of MiR-155 and MiR-23a manipulates Klebsiella pneumoniae Adhesion on Human pulmonary Epithelial cells via Integrin α5β1 Signaling.

Authors:  Yan Teng; Junming Miao; Xiaofei Shen; Xiaolong Yang; Xinyuan Wang; Laibin Ren; Xiaoying Wang; Junli Chen; Jingyu Li; Shanze Chen; Yi Wang; Ning Huang
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

9.  Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.

Authors:  Alicia E Woock; Jacqueline M Grible; Amy L Olex; J Chuck Harrell; Patricija Zot; Michael Idowu; Charles V Clevenger
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

10.  Exogenous HMGN2 inhibits the migration and invasion of osteosarcoma cell lines.

Authors:  Enjie Xu; Heng Jiang; Tao Lin; Yichen Meng; Xiao Ma; Jia Yin; Jun Ma; Xuhui Zhou
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.